Grenco Science and Vapium Announce Joint Venture to Introduce Accudose
LOS ANGELES, Aug. 13, 2019 /PRNewswire/ -- Grenco Science, the leader in advanced technology cannabis vaporization, announces a joint venture with Vapium, the award-winning vaporization company and resident of Johnson & Johnson Innovation - JLABS (JLABS), and investee of Canopy Growth. The companies will work together to integrate ground-breaking technologies for the medical cannabis industry under the brand name Accudose. The first-of-its-kind cannabis consumption platform will fill a void in the market for an accurate, dosing protocol that will allow practitioners to prescribe cannabis as medicine, reframing cannabis consumption.
